Overexpression of BCR::ABL1 protein due to amplification of BCR::ABL1 fusion gene was first identified in imatinib resistant CML cell lines [17]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.